(Q45160212)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7852216%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

title

Clinical application of recombinant erythropoietin in the anemia of chronic disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7852216%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7852216%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

author name string

Means RT Jr

series ordinal

1

1 reference

10 December 2017

publication date

1 October 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7852216%20AND%20SRC:MED&resulttype=core&format=json

Hematology / Oncology Clinics of North America

27 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7852216%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7852216%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7852216%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

933-944

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7852216%20AND%20SRC:MED&resulttype=core&format=json

Blunted erythropoietin response to anaemia in rheumatoid arthritis

27 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930139-4

7 January 2021

EVIDENCE FOR TUMOUR NECROSIS FACTOR/CACHECTIN PRODUCTION IN CANCER

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930139-4

7 January 2021

Cachectin: more than a tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930139-4

7 January 2021

Tumour necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930139-4

7 January 2021

The anemia of chronic disease: spectrum of associated diseases in a series of unselected hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930139-4

7 January 2021

Interleukin 1: an immunological perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930139-4

7 January 2021

Interleukin-1 and its biologically related cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930139-4

7 January 2021

Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930139-4

7 January 2021

Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930139-4

7 January 2021

Experience with daily self-administered subcutaneous erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930139-4

7 January 2021

Response of anaemia in rheumatoid arthritis to treatment with subcutaneous recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930139-4

7 January 2021

Serum immunoreactive erythropoietin in rheumatoid arthritis: impaired response to anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930139-4

7 January 2021

Immune Interferon in the Circulation of Patients with Autoimmune Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930139-4

7 January 2021

Suppression of normal human erythropoiesis by gamma interferon in vitro. Role of monocytes and T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930139-4

7 January 2021

Treatment with gamma-interferon triggers the onset of collagen arthritis in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930139-4

7 January 2021

Anaemia in rheumatoid arthritis: role of cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930139-4

7 January 2021

Mechanism of anaemia in rheumatoid arthritis: demonstration of raised interleukin 1 beta concentrations in anaemic patients and of interleukin 1 mediated suppression of normal erythropoiesis and proliferation of human erythroleukaemia (HEL) cells in

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930139-4

7 January 2021

Inhibition of human erythroid colony-forming units by tumor necrosis factor requires beta interferon.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930139-4

7 January 2021

Inhibition of human colony-forming-unit erythroid by tumor necrosis factor requires accessory cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930139-4

7 January 2021

Inhibition of human erythroid colony-forming units by interleukin-1 is mediated by gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930139-4

7 January 2021

Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin: clinical and in vitro studies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930139-4

7 January 2021

Decreased erythropoietin response in patients with the anemia of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930139-4

7 January 2021

Cachectin/tumor necrosis factor-alpha alters red blood cell kinetics and induces anemia in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930139-4

7 January 2021

Interferon-gamma, the activated macrophage, and host defense against microbial challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930139-4

7 January 2021

Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930139-4

7 January 2021

Purification of human erythroid colony-forming units and demonstration of specific binding of erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930139-4

7 January 2021

Immunological aspects of the anemia of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930139-4

7 January 2021

Use of recombinant human erythropoietin to enhance autologous blood donation in a patient with multiple red cell allo-antibodies and the anemia of chronic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930139-4

7 January 2021

Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930139-4

7 January 2021

Phase I trial of recombinant interferon gamma in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930139-4

7 January 2021

In vitro suppression of erythropoiesis by bone marrow adherent cells from some patients with fungal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930139-4

7 January 2021

10.1016/S0889-8588(18)30139-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7852216%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference